Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fluorine-18-Florbetapir - Genentech/Molecular Neuroimaging

Next Previous
X
Search
Drug Profile

Fluorine-18-Florbetapir - Genentech/Molecular Neuroimaging

Alternative Names: [18F]florbetapir; [18F]G02941054; [18F]GTP1; [18F]MNI-798; F-18-MNI-798; Fluorine 18 MNI-798

Latest Information Update: 28 Aug 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Genentech
  • Developer Genentech; Molecular NeuroImaging
  • Class Imaging agents; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Small molecules
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Alzheimer's disease

Most Recent Events

  • 16 Jul 2023 Pharmacodynamics data from preclinical trial in Alzheimer’s disease presented at the Alzheimer's Association International Conference (AAIC-2023)
  • 27 Jun 2023 Genentech completes a phase I trial in Alzheimer's disease (Diagnosis) in USA (NCT04566003)
  • 19 Jul 2022 Washington University School of Medicine in collaboration with Roche Pharma initiates a phase I trial in Alzheimer's disease (Diagnosis, In adults, In the elderly) in USA (NCT05464368)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top